Gene · 22918
Papers1,470
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,470
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lupus Nephritis Risk Factors and Biomarkers: An Update. | Int J Mol Sci | 2023 | 37833974 | PubTator, text mining | PubMed |
| Linking Mechanisms of Vitamin D Signaling with Multiple Sclerosis. | Cells | 2023 | 37830605 | PubTator, text mining | PubMed |
| A data integration approach unveils a transcriptional signature of type 2 diabetes progression in rat and human islets. | PLoS One | 2023 | 37816033 | PubTator, text mining | PubMed |
| Identification of Clinically Relevant Brain Endothelial Cell Biomarkers in Plasma. | Stroke | 2023 | 37814955 | PubTator, text mining | PubMed |
| Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy. | Front Immunol | 2023 | 37809078 | PubTator, text mining | PubMed |
| Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation. | Front Immunol | 2023 | 37771589 | PubTator, text mining | PubMed |
| Structural biology of complement receptors. | Front Immunol | 2023 | 37753090 | PubTator, text mining | PubMed |
| Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis. | Front Immunol | 2023 | 37753072 | PubTator, text mining | PubMed |
| Innate and adaptive AAV-mediated immune responses in a mouse model of Duchenne muscular dystrophy. | Mol Ther Methods Clin Dev | 2023 | 37746243 | PubTator, text mining | PubMed |
| Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody. | bioRxiv | 2023 | 37745410 | PubTator, text mining | PubMed |
| Development and Characterization of Proteomic Aging Clocks in the Atherosclerosis Risk in Communities (ARIC) Study. | medRxiv | 2023 | 37732184 | PubTator, text mining | PubMed |
| Public RNA-seq data-based identification and functional analyses reveal that MXRA5 retains proliferative and migratory abilities of dental pulp stem cells. | Sci Rep | 2023 | 37730838 | PubTator, text mining | PubMed |
Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients. | Front Immunol | 2023 | 37727789 | PubTator, text mining | PubMed |
| Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond. | Front Physiol | 2023 | 37711466 | PubTator, text mining | PubMed |
| YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice. | Front Pharmacol | 2023 | 37693903 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells. | J Transl Med | 2023 | 37689642 | PubTator, text mining | PubMed |
| Hub genes in adenocarcinoma of the esophagogastric junction based on weighted gene co-expression network analysis and immunohistochemistry. | Transl Oncol | 2023 | 37689006 | PubTator, text mining | PubMed |
| The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential. | Int J Mol Sci | 2023 | 37686315 | PubTator, text mining | PubMed |
| CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them. | Hemasphere | 2023 | 37674860 | PubTator, text mining | PubMed |
| Neutrophil metalloproteinase driven spleen damage hampers infection control of trypanosomiasis. | Nat Commun | 2023 | 37669943 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22918/papers?page=8